Vuzix And VSee Partner For Telemedicine Smart Glasses Solution

Healthcare News

Vuzix_And-VSee-Partner-For-Telemedicine-Smart-Glasses-Solution Vuzix And VSee Partner For Telemedicine Smart Glasses SolutionThe American multinational tech firm, Vuzix that supplies Smart Glasses and Augmented Reality (AR) technology and products, has teamed with VSee, a San Jose-based proprietary low-bandwidth, group video chat and screen-sharing software company. The partnership has aimed at offering smart glasses telemedicine solution for real-time video. VSee offers a HIPAA-compliant video telehealth and telemedicine video conferencing solution to over 1,000 telemedicine companies operating all over the globe.

VSee will be demonstrating the smart glasses telehealth and telemedicine solution on the Vuzix M300XL and Vuzix Blade at the American Telemedicine Association (ATA) 2019 annual conference and expo in New Orleans. Ahead of the partnership, VSee Chief Executive Officer Milton Chen said that while VSee previously worked with some early generation smart glasses solutions, the technology was not ready for telemedicine. We feel very privileged now to be partnering with Vuzix with its mature smart glasses offerings. He further noted that telemedicine video conferencing through smart glasses from Vuzix is a natural progression from tablets and computers for our customers.  We are excited to begin realizing telehealth smart glasses applications from remote training on imaging technology (CTs, ultrasounds) and inserting IVs to telesurgery to AR-enhanced video visits.  We look forward to continued collaboration between our two companies, Chen added.

The VSee video telehealth and telemedicine video conferencing solution utilized by MDLIVE, McKesson, Walgreens, International SOS, and DaVita, in addition to several A-list healthcare systems like Ascension, Sutter, HealthPartners, Trinity, and Sentara. For the Vuzix M300XL and Vuzix Blade Smart Glasses, the VSee telehealth and telemedicine solution is expected to be commercially available during the Q2 of this year.